Go Back
Lyra Therapeutics, Inc. reports $16.3 million Q1 loss
By USInMinutes - May 12, 2023, 08:49 AM ET
Last Updated - Jul 18, 2023, 03:30 PM EDT
The company generated $0.41 million in quarterly revenue
Lyra Therapeutics, Inc. [LYRA] has reported fiscal Q1 loss of $16.30 million.
On a per-share basis, the DE based company said its diluted earnings are $0.44.
The Surgical & Medical Instruments & Apparatus firm posted revenue of $0.41 million in this period.
Also Read:
- Lyra Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
- Lyra Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
- Lyra Therapeutics Announces Restart of Pivotal Phase 3 ENLIGHTEN II Clinical Trial of LYR-210 ...
- Lyra Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides ...
- Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News